AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
October 7-10, 2021
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Notice of Termination and Rescheduling
The American Association for Cancer Research (AACR) has made the difficult decision, after careful consideration and a comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to terminate the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics originally scheduled for October 7-11, 2021 in Boston, MA.
A virtual conference will take place from October 7-10, 2021.
We recognize that the new data, exchange of information, and opportunities for collaboration offered by this conference are highly valued by the cancer research community; therefore, we are planning to present all of the content outlined in the original program virtually from October 7-10, 2021.
The AACR deeply appreciates your patience and understanding during this unfortunate situation. If you have any questions, please email [email protected]
Our heartfelt sympathies go out to everyone who has been impacted by this global health crisis. Thank you for your dedication to the AACR and to its mission.
Scientific Committee Cochairs
Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
James L. Gulley, National Cancer Institute, Bethesda, Maryland
Ruth Plummer, Northern Centre for Cancer Care, Newcastle upon Tyne, United Kingdom
Organizing Committee Cochairs
Antoni Ribas, University of California Los Angeles (UCLA), Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, California
James H. Doroshow, National Cancer Institute, Bethesda, Maryland
Denis A. Lacombe, European Organisation for Research and Treatment of Cancer, Brussels, Belgium